GO:0042559 pteridine-containing compound biosynthetic process: Folate Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042559 describes the biosynthesis of pteridine-containing compounds, including pteroic acid, xanthopterin, and folic acid, as defined by QuickGO.
• Pteridine biosynthesis is essential for folate-mediated one-carbon metabolism, nucleotide synthesis, and amino acid homeostasis.
• Pteridines participate in electron transfer and photosynthetic phosphorylation, as shown by stimulation of photophosphorylation in vitro.
• Analytical methods such as fluorometric HPLC enable quantification of pteridine derivatives and antifolate metabolites.
• Transcriptomic and proteomic studies reveal that pteridine-related metabolic processes are dynamically regulated in development and disease [1,2].
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect pteridine biosynthetic gene function.
Description
Pteridine-containing compound biosynthetic process (GO:0042559) is a biological process defined by the Gene Ontology as the chemical reactions and pathways resulting in the formation of any compound containing pteridine, such as pteroic acid, xanthopterin, and folic acid. This process is fundamental to cellular metabolism because pteridine derivatives serve as essential cofactors and signaling molecules. Folate, a pteridine-containing compound, is required for one-carbon transfer reactions that support nucleotide biosynthesis and amino acid metabolism. Beyond folate, other pteridines such as xanthopterin have been implicated in electron transfer and photosynthetic phosphorylation, as demonstrated by early biochemical studies showing that pteridines stimulate photophosphorylation. The broad relevance of pteridine biosynthesis spans microbial, plant, and animal systems, making it a subject of intense research interest. Understanding the genes and enzymes that drive this process is critical for developing therapeutic strategies against diseases linked to metabolic dysfunction. Recent advances in transcriptomics and proteomics have begun to uncover how pteridine biosynthetic pathways are regulated in complex biological contexts [1,2].
pteridine-containing compound biosynthetic process At A Glance
| GO ID | GO:0042559 |
|---|---|
| GO term | pteridine-containing compound biosynthetic process |
| Ontology | biological_process |
| Synonym | pteridine and derivative biosynthesis; pterin biosynthesis; pteridine-containing compound formation |
| Definition | The chemical reactions and pathways resulting in the formation of any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid. |
| Major function | Biosynthesis of pteridine-based cofactors and metabolites, including folate and xanthopterin. |
| Related pathways | Folate biosynthesis, one-carbon metabolism, electron transfer. |
| Key enzymes | GTP cyclohydrolase I, dihydroneopterin aldolase, dihydropteroate synthase, dihydrofolate reductase. |
What Is GO:0042559?
GO:0042559, pteridine-containing compound biosynthetic process, refers to the set of biochemical reactions and pathways that produce molecules containing a pteridine ring system, specifically pyrazino(2,3-dipyrimidine). This includes the synthesis of pteroic acid, xanthopterin, and folic acid. The term encompasses anabolic steps that build these compounds from simpler precursors, as opposed to their degradation or interconversion. It is a biological process ontology term, and its synonyms include pteridine and derivative biosynthesis, pterin biosynthesis, and pteridine-containing compound formation.
Why Is pteridine-containing compound biosynthetic process Important in Cell Biology?
Pteridine-containing compound biosynthesis is essential for life because it produces folate and related cofactors that drive one-carbon metabolism, nucleotide synthesis, and amino acid interconversion. Disruption of this pathway leads to metabolic imbalances that are associated with developmental defects, anemia, and cancer. In addition, pteridines such as xanthopterin participate in electron transfer reactions, as evidenced by their ability to stimulate photosynthetic phosphorylation in vitro. The pathway is also a target for antimicrobial and anticancer drugs, since inhibition of folate biosynthesis selectively affects rapidly dividing cells. Consequently, understanding the regulation and enzymology of pteridine biosynthesis has broad implications for medicine and biotechnology [1,2].
• Provides folate cofactors required for DNA synthesis and repair.
• Supports one-carbon metabolism and amino acid homeostasis.
• Participates in electron transfer and photosynthetic phosphorylation.
• Is a target for antifolate drugs used in cancer and infectious diseases.
• Its dysregulation is linked to metabolic and proliferative disorders.
• Enables analytical detection of pteridine derivatives via fluorometric HPLC.
• Is dynamically regulated during development and in response to nutritional status.
• Offers opportunities for CRISPR-based functional genomics.
What Happens During pteridine-containing compound biosynthetic process?
Initiation: GTP cyclohydrolase I and the first committed step
In simple terms: The pathway starts by converting a common nucleotide into a pteridine ring.
The biosynthesis of pteridine-containing compounds typically begins with the conversion of GTP to dihydroneopterin triphosphate by GTP cyclohydrolase I. This enzyme catalyzes the first committed step in folate and pterin biosynthesis. In plants and microorganisms, this step is essential for producing folate, while in animals, it is required for tetrahydrobiopterin synthesis. The reaction involves opening the GTP ring and rearranging it into a pteridine structure. This step is regulated by feedback inhibition from downstream products. The importance of this initiation step is underscored by the fact that its inhibition leads to folate auxotrophy in many organisms.
Intermediate steps: Formation of pteroic acid and folate
In simple terms: The pteridine ring is modified and combined with other molecules to make folate.
Following the initial synthesis of dihydroneopterin triphosphate, a series of enzymatic reactions lead to the formation of pteroic acid and subsequently folate. Dihydroneopterin aldolase and dihydropteroate synthase are key enzymes in this process. Dihydropteroate synthase catalyzes the condensation of 6-hydroxymethyl-7,8-dihydropterin pyrophosphate with p-aminobenzoic acid to form dihydropteroate, a precursor of folate. This step is the target of sulfonamide antibiotics. Subsequent glutamylation and reduction steps yield tetrahydrofolate, the active cofactor. These reactions are conserved across bacteria, plants, and some protozoa, but mammals lack the enzymes for de novo folate synthesis and must obtain folate from the diet.
Alternative branches: Xanthopterin and other pteridines
In simple terms: Some pteridines are made through different branches of the pathway.
Beyond folate, the pteridine biosynthetic process can produce other compounds such as xanthopterin. Xanthopterin is a yellow pigment found in insects and other organisms, and it has been shown to stimulate photosynthetic phosphorylation in isolated chloroplasts. The exact biosynthetic routes to xanthopterin are less well characterized than folate biosynthesis, but they likely involve oxidation and deamination of pterin intermediates. These alternative branches contribute to the diversity of pteridine-containing compounds and their biological functions, which range from pigmentation to electron transfer.
Regulation and integration with cellular metabolism
In simple terms: The pathway is turned on or off depending on the cell's needs.
Pteridine biosynthesis is tightly regulated in response to cellular demand for folate and other pteridines. In bacteria, the expression of folate biosynthetic genes is controlled by the folate-responsive repressor FolR or by riboswitches. In plants, the pathway is regulated by developmental and environmental cues. In mammals, while de novo synthesis does not occur, the salvage and interconversion of pteridines are regulated by enzymes such as dihydrofolate reductase. Transcriptomic studies in ruminants have shown that metabolic processes, including pteridine-related pathways, are enhanced during rumen development, suggesting nutritional regulation. Proteomic analyses in sepsis patients have revealed alterations in proteins related to pteridine metabolism, linking this pathway to systemic inflammation.
Key Genes Involved in GO:0042559 pteridine-containing compound biosynthetic process
The following genes and enzymes are central to the pteridine-containing compound biosynthetic process, based on their established roles in folate and pterin biosynthesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCH1 | GTP cyclohydrolase I, first committed step | Target for tetrahydrobiopterin disorders; knockout models |
| PTPS | 6-pyruvoyltetrahydropterin synthase | Involved in BH4 synthesis; mutations cause hyperphenylalaninemia |
| DHFR | Dihydrofolate reductase, reduces dihydrofolate to tetrahydrofolate | Target of methotrexate; essential for folate cycle |
| DHPS | Dihydropteroate synthase, condenses pterin with PABA | Target of sulfonamide antibiotics |
| FOLC | Bifunctional dihydrofolate synthase/folylpolyglutamate synthase | Required for folate polyglutamylation |
| FOLP | Dihydroneopterin aldolase | Involved in pterin ring modification |
| FOLK | 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase | Phosphorylates pterin intermediate |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase | Links folate cycle to one-carbon metabolism |
| MTHFR | Methylenetetrahydrofolate reductase | Regulates folate distribution; common polymorphism |
| SHMT1 | Serine hydroxymethyltransferase | Provides one-carbon units for folate cycle |
| TYMS | Thymidylate synthase | Uses folate cofactor for dTMP synthesis |
| ATIC | AICAR transformylase/IMP cyclohydrolase | Uses folate for purine synthesis |
| GART | Glycinamide ribonucleotide transformylase | Folate-dependent purine synthesis |
| MTR | Methionine synthase | Folate-dependent methionine synthesis |
| BHMT | Betaine-homocysteine methyltransferase | Alternative methyl donor pathway |
| SPR | Sepiapterin reductase | Final step in BH4 synthesis |
| PTS | 6-pyruvoyltetrahydropterin synthase | BH4 biosynthesis |
| QDPR | Quinoid dihydropteridine reductase | Recycles BH4 cofactor |
How Is pteridine-containing compound biosynthetic process Regulated?
Pteridine biosynthesis is regulated at multiple levels. In bacteria, the pathway is controlled by feedback inhibition and transcriptional regulators such as FolR. In plants, light and developmental signals influence enzyme expression. In mammals, although de novo synthesis is absent, the salvage and interconversion of pteridines are regulated by dihydrofolate reductase and other enzymes. Transcriptomic analysis in Hu lambs revealed that metabolic processes, including those related to pteridine metabolism, are enhanced in the rumen during development, suggesting nutritional regulation. Proteomic profiling in sepsis patients identified alterations in proteins associated with pteridine metabolism, indicating that systemic inflammation can impact this pathway.
pteridine-containing compound biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DHFR | Cancer, antifolate resistance | Knockout and point mutation in cancer cell lines |
| GCH1 | Hyperphenylalaninemia, BH4 deficiency | Knock-in of patient mutations in iPSCs |
| MTHFR | Cardiovascular disease, neural tube defects | Overexpression and knockout in endothelial cells |
| MTR | Homocystinuria, folate deficiency | Knockout in hepatocytes |
| FOLC | Folate deficiency, developmental defects | Knock-in of hypomorphic alleles in zebrafish |
Cancer and antifolate therapy
Pteridine-containing compound biosynthesis is critical for cancer cell proliferation because folate cofactors are required for nucleotide synthesis. Antifolates such as methotrexate and 10-deazaaminopterin target dihydrofolate reductase and related enzymes, thereby inhibiting DNA synthesis and cell division. The analytical detection of these drugs and their metabolites in biological samples is essential for therapeutic monitoring. Consequently, genes in this pathway are prime targets for cancer chemotherapy and for CRISPR-based studies of drug resistance.
Metabolic and inflammatory disorders
Dysregulation of pteridine metabolism has been observed in sepsis and sarcopenia. Proteome sequencing of sepsis patients revealed changes in proteins related to pteridine biosynthesis, suggesting a link between this pathway and muscle wasting. These findings highlight the potential of targeting pteridine metabolism to modulate inflammatory and metabolic diseases.
Nutritional and developmental disorders
Folate deficiency, caused by impaired pteridine biosynthesis or dietary insufficiency, leads to megaloblastic anemia and neural tube defects. In livestock, transcriptome analysis showed that alfalfa promotes rumen development through enhanced metabolic processes, including pteridine-related pathways. This underscores the importance of pteridine biosynthesis in growth and development across species.
From pteridine-containing compound biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of DHFR reduce cell proliferation? | CRISPR knockout in HeLa or HEK293T cells |
| Can a point mutation in GCH1 mimic disease phenotype? | CRISPR point mutation knock-in in iPSCs |
| Does overexpression of MTHFR alter folate metabolism? | CRISPR overexpression in HepG2 cells |
| What is the role of FOLC in development? | Knock-in of tagged FOLC in zebrafish |
| How does folate biosynthesis affect drug sensitivity? | CRISPR library screening in cancer cells |
| Can pteridine biosynthesis be rewired in bacteria? | CRISPR interference in E. coli |
How to Study the pteridine-containing compound biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Transcriptomic profiling of pteridine pathway genes |
| Proteomics | Protein abundance and modifications | Identifying biomarkers in sepsis |
| Fluorometric HPLC | Concentration of pteridines and antifolates | Pharmacokinetic studies |
| Enzyme activity assay | Catalytic activity of biosynthetic enzymes | Functional validation of CRISPR mutants |
| CRISPR knockout | Loss-of-function phenotypes | Determining gene essentiality |
| CRISPR knock-in | Precise mutation introduction | Modeling disease-associated variants |
| CRISPR overexpression | Gain-of-function effects | Studying pathway activation |
| CRISPR library screening | Pooled fitness screens | Identifying synthetic lethal interactions |
Transcriptomic profiling of pteridine pathway genes
RNA-seq can quantify the expression of genes involved in pteridine biosynthesis under different conditions. For example, transcriptome analysis in Hu lambs revealed that metabolic processes, including pteridine-related pathways, are upregulated during rumen development. This method is useful for identifying regulatory nodes and potential therapeutic targets.
Proteomic analysis of pteridine enzymes
Proteome sequencing allows the detection of protein-level changes in pteridine biosynthetic enzymes. In sepsis patients, proteomic profiling identified alterations in proteins associated with pteridine metabolism, linking the pathway to systemic inflammation. This approach can uncover post-transcriptional regulation and biomarker candidates.
Fluorometric HPLC for pteridine quantification
Fluorometric high-performance liquid chromatography (HPLC) is a sensitive method for analyzing pteridine derivatives and antifolate drugs. Kinahan et al. developed an HPLC method to quantify 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and their metabolites. This technique is essential for pharmacokinetic studies and for measuring pathway flux.
Biochemical assays for enzyme activity
Enzymatic assays using recombinant proteins or cell lysates can measure the activity of key enzymes such as GTP cyclohydrolase I and dihydrofolate reductase. These assays are often coupled with spectrophotometric or fluorometric detection. They are valuable for validating CRISPR-generated mutations and for screening inhibitors.
How CRISPR Can Be Used to Study GO:0042559 pteridine-containing compound biosynthetic process
Knockout
CRISPR knockout is used to create loss-of-function mutations in genes encoding pteridine biosynthetic enzymes. For example, knocking out DHFR in cancer cell lines can reveal its essentiality and sensitivity to antifolates. Knockout models are also valuable for studying the role of GCH1 in tetrahydrobiopterin synthesis and disease.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated variants, such as MTHFR C677T, into cell lines or iPSCs. These models help dissect the functional consequences of single nucleotide changes on enzyme activity and pathway flux.
Knock-in
Knock-in of tagged versions of pteridine biosynthetic enzymes, such as GFP-tagged DHFR, enables live-cell imaging and proteomic analysis. This approach can reveal subcellular localization and dynamic regulation of the pathway.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive high-level expression of pteridine biosynthetic genes. Overexpression models are useful for studying pathway saturation, drug resistance, and metabolic reprogramming in cancer cells.
How EDITGENE Supports pteridine-containing compound biosynthetic process Research
Researchers studying pteridine-containing compound biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for pteridine-containing compound biosynthetic process research.
Frequently Asked Questions About pteridine-containing compound biosynthetic process
What is GO:0042559?
GO:0042559 is the Gene Ontology term for pteridine-containing compound biosynthetic process, which describes the chemical reactions and pathways that produce pteridine-containing compounds such as pteroic acid, xanthopterin, and folic acid.
What genes are involved in pteridine-containing compound biosynthetic process?
Key genes include GCH1, DHFR, DHPS, MTHFR, MTR, and FOLC, among others. These genes encode enzymes that catalyze the steps of pteridine and folate biosynthesis.
Why is pteridine biosynthesis important?
It is essential for producing folate cofactors required for nucleotide synthesis, amino acid metabolism, and one-carbon transfer reactions. It also plays a role in electron transfer and is a target for antifolate drugs [1,3,4].
What diseases are associated with pteridine biosynthesis defects?
Defects can lead to megaloblastic anemia, neural tube defects, hyperphenylalaninemia, and increased susceptibility to infections. Altered pteridine metabolism has also been observed in sepsis and cancer [1,4].
How can I study pteridine biosynthesis using CRISPR?
CRISPR knockout, point mutation knock-in, and overexpression models can be used to dissect gene function. EDITGENE offers these services for genes in the pteridine pathway.
What methods are used to measure pteridine compounds?
Fluorometric HPLC is a sensitive method for quantifying pteridines and antifolates. RNA-seq and proteomics can measure pathway gene expression and protein levels [1,2].
Is pteridine biosynthesis conserved across species?
The pathway is conserved in bacteria, plants, and some protozoa, but mammals lack the de novo folate synthesis enzymes and must obtain folate from the diet.
What is the role of xanthopterin in photosynthesis?
Xanthopterin has been shown to stimulate photosynthetic phosphorylation in isolated chloroplasts, suggesting a role in electron transfer.
Can pteridine biosynthesis be targeted for cancer therapy?
Yes, antifolates such as methotrexate target dihydrofolate reductase, a key enzyme in the pathway, to inhibit DNA synthesis in cancer cells.
How does nutrition affect pteridine biosynthesis?
Transcriptomic studies in ruminants show that nutritional factors like alfalfa can enhance metabolic processes, including pteridine-related pathways, during rumen development.
Conclusion
Pteridine-containing compound biosynthetic process (GO:0042559) is a fundamental metabolic pathway that produces folate, xanthopterin, and related cofactors essential for nucleotide synthesis, amino acid metabolism, and electron transfer. Its dysregulation is linked to cancer, metabolic disorders, and developmental defects. Advances in transcriptomics, proteomics, and CRISPR-based gene editing are providing new insights into the regulation and therapeutic potential of this pathway. EDITGENE offers a comprehensive suite of CRISPR services to support research on pteridine biosynthesis and its associated genes.
References
- 1. Jiang A et al.. 2025. [Exploring the potential causes of sarcopenia in sepsis patients based on proteome sequencing].. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 37(11):1006-1012 PMID: 41437585
- 2. Yang B et al.. 2019. Transcriptome Analysis Reveals That Alfalfa Promotes Rumen Development Through Enhanced Metabolic Processes and Calcium Transduction in Hu Lambs.. Front Genet 10:929 PMID: 31632445
- 3. MACLEAN FI et al.. 1965. PHOTOSYNTHETIC PHOSPHORYLATION: STIMULATION BY PTERIDINES AND A COMPARISON WITH PHOSPHODOXIN.. Science 149(3684):636-8 PMID: 14331184
- 4. Kinahan JJ et al.. 1985. Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolites.. Anal Biochem 150(1):203-13 PMID: 2417507
